Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Home use hair removal device, model: Precise Touch Pro

K-Number: K213830 · 2022-02-01

ApplicantIluminage Beauty Co., Limited
Decision Date2022-02-01
Product CodeOHT
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Home use hair removal device, model: Precise Touch Pro is a medical device manufactured by Iluminage Beauty Co., Limited. It received FDA 510(k) clearance on 2022-02-01 under approval number K213830. The device is classified under product code OHT. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Home use hair removal device, model: Precise Touch Pro?

Home use hair removal device, model: Precise Touch Pro is a medical device that received FDA 510(k) clearance on 2022-02-01. It is manufactured by Iluminage Beauty Co., Limited. The 510(k) number is K213830.

When was Home use hair removal device, model: Precise Touch Pro approved by the FDA?

Home use hair removal device, model: Precise Touch Pro received FDA 510(k) clearance on 2022-02-01, under approval number K213830.

What company makes Home use hair removal device, model: Precise Touch Pro?

Home use hair removal device, model: Precise Touch Pro is manufactured by Iluminage Beauty Co., Limited.

What is the FDA product code for Home use hair removal device, model: Precise Touch Pro?

The FDA product code for Home use hair removal device, model: Precise Touch Pro is OHT.

Related Clinical Trials

NCT05150197 Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease RECRUITING NCT06291818 Self-Adhering Magnetic Device to Treat Corneal Exposure RECRUITING NCT07595835 CT-guided Percutaneous Radionuclide Therapy With 32P Microparticles in Patients With Non-progressive Locally Advanced Pancreatic Cancer RECRUITING NCT07062094 Safety and Effectiveness of Orbera365™ Intragastric Balloon System RECRUITING NCT07034521 The Feasibility and Therapeutic Effect of Hybrid End-effector Robot-assisted Gait Training With an Active-assisted Module in Chronic Stroke Survivors RECRUITING NCT07593872 XR-Assisted PET/CT Navigation for Cervical Lymph Node Dissection in Lung Cancer NOT_YET_RECRUITING

Related PubMed Literature

PMID: 42082885 Precision Dosing of Vancomycin: A Systematic Review of Population Pharmacokinetics Models and Comparative Evaluation of Software Tools. Clinical pharmacokinetics (2026) PMID: 41915420 Analysis Model for Infant Incubator Adverse Events Using Retrieval-Augmented Generation Combined With Dual-Adapter Fine-Tuning: Development and Evaluation Study. JMIR medical informatics (2026) PMID: 41831468 Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model study. The lancet. Psychiatry (2026) PMID: 41501972 First Application of an Eddy-Scale Hemolysis Model to the Food and Drug Administration Nozzle Using Computational Fluid Dynamics. ASAIO journal (American Society for Artificial Internal Organs : 1992) (2026)

Related Devices (Code: OHT)

K162231iPulse SmoothSkin Gold Hair Removal Device, Venus Silk.expertCyden Limited K161089sensiLight MiniEl Global Trade, Ltd. K160968iPulse SmoothSkin Gold Hair Removal DeviceCyden Limited K172181micro IPLEl Global Trade, Ltd. K171433Silk'n InfinityHome Skinovations , Ltd. K170269Hee HR MiniOriental Inspiration Limited

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑